BeiGene Statistics
Total Valuation
BeiGene has a market cap or net worth of 20.64 billion. The enterprise value is 18.98 billion.
Market Cap | 20.64B |
Enterprise Value | 18.98B |
Important Dates
The last earnings date was Wednesday, November 13, 2024.
Earnings Date | Nov 13, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
Current Share Class | n/a |
Shares Outstanding | n/a |
Shares Change (YoY) | -0.07% |
Shares Change (QoQ) | +0.26% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 57.41M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
PB Ratio | n/a |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -22.21 |
EV / Sales | 5.66 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | -15.93 |
Financial Position
The company has a current ratio of 1.94, with a Debt / Equity ratio of 0.31.
Current Ratio | 1.94 |
Quick Ratio | 1.64 |
Debt / Equity | 0.31 |
Debt / EBITDA | n/a |
Debt / FCF | -0.88 |
Interest Coverage | -57.74 |
Financial Efficiency
Return on equity (ROE) is -23.22% and return on invested capital (ROIC) is -12.29%.
Return on Equity (ROE) | -23.22% |
Return on Assets (ROA) | -9.58% |
Return on Capital (ROIC) | -12.29% |
Revenue Per Employee | 316,161 |
Profits Per Employee | -80,606 |
Employee Count | 10,600 |
Asset Turnover | 0.58 |
Inventory Turnover | 1.44 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +8.47% in the last 52 weeks. The beta is 0.62, so BeiGene's price volatility has been lower than the market average.
Beta (5Y) | 0.62 |
52-Week Price Change | +8.47% |
50-Day Moving Average | n/a |
200-Day Moving Average | n/a |
Relative Strength Index (RSI) | n/a |
Average Volume (20 Days) | 679 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | 3.43 |
Income Statement
In the last 12 months, BeiGene had revenue of 3.35 billion and -854.42 million in losses. Loss per share was -8.19.
Revenue | 3.35B |
Gross Profit | 2.80B |
Operating Income | -886.48M |
Pretax Income | -801.31M |
Net Income | -854.42M |
EBITDA | -794.98M |
EBIT | -886.48M |
Loss Per Share | -8.19 |
Balance Sheet
The company has 2.71 billion in cash and 1.05 billion in debt, giving a net cash position of 1.66 billion.
Cash & Cash Equivalents | 2.71B |
Total Debt | 1.05B |
Net Cash | 1.66B |
Net Cash Per Share | n/a |
Equity (Book Value) | 3.45B |
Book Value Per Share | 32.32 |
Working Capital | 1.89B |
Cash Flow
In the last 12 months, operating cash flow was -649.87 million and capital expenditures -541.71 million, giving a free cash flow of -1.19 billion.
Operating Cash Flow | -649.87M |
Capital Expenditures | -541.71M |
Free Cash Flow | -1.19B |
FCF Per Share | n/a |
Margins
Gross margin is 83.67%, with operating and profit margins of -26.45% and -25.50%.
Gross Margin | 83.67% |
Operating Margin | -26.45% |
Pretax Margin | -23.91% |
Profit Margin | -25.50% |
EBITDA Margin | -23.72% |
EBIT Margin | -26.45% |
FCF Margin | -35.56% |
Dividends & Yields
BeiGene does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | 0.07% |
Shareholder Yield | 0.07% |
Earnings Yield | n/a |
FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
BeiGene has an Altman Z-Score of 2.96. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | 2.96 |
Piotroski F-Score | n/a |